ProShares Ultra Nasdaq Biotechnology (BIB) Dipped -5.2% or -2.9 To Price $52.86 On Friday


ProShares Ultra Nasdaq Biotechnology (BIB) dipped -5.2% or -2.9 to $52.86. It is approximately 131579 shares traded, which is 58.28% compare to the average total volume 225770. The market cap of BIB is $237.87 million. The year to date change is 24.47%. The 52 week price range is from $36.05 to $70.82. Price of BIB have changed -3.86% during last week. It have changed -0.66% over last month, 21.61% over last 3 months, -11.94% over last 6 months and -9.13% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for BIB is 54.64. It is 3.37% above current price. The 200-day Moving Averages for BIB is 57.50. It is 8.78% above current price. The 52-week High is 70.82. It is 33.98% from the current price. The 52-week Low is 36.05. It is -31.80% from current price.

There are some statistics of BIB. It is has market cap $237.87 million. The share outstanding is 4.50 million. The average volume is 225770. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of BIB is 10.33%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of BIB is -1.99%.


Tags:

Share this post